Presendin™ (Exenatide)
Idiopathic Intracranial Hypertension (IIH)
Phase 2/3Active
Key Facts
Indication
Idiopathic Intracranial Hypertension (IIH)
Phase
Phase 2/3
Status
Active
About Invex Therapeutics
Repurposing Exenatide to treat raised intracranial pressure in neurology.
View full company profileAbout Invex Therapeutics
Repurposing Exenatide to treat raised intracranial pressure in neurology.
View full company profileAbout Invex Therapeutics
Repurposing Exenatide to treat raised intracranial pressure in neurology.
View full company profile